Charles Bennett to Drug Utilization Review
This is a "connection" page, showing publications Charles Bennett has written about Drug Utilization Review.
Connection Strength
0.434
-
Systematic review of piperacillin-induced neutropenia. Drug Saf. 2007; 30(4):295-306.
Score: 0.270
-
Reassessments of ESAs for cancer treatment in the US and Europe. Oncology (Williston Park). 2010 Mar; 24(3):260-8.
Score: 0.084
-
Quality of reporting of serious adverse drug events to an institutional review board: a case study with the novel cancer agent, imatinib mesylate. Clin Cancer Res. 2009 Jun 01; 15(11):3850-5.
Score: 0.080